Marina Makrecka-Kuka, PhD
Marina Makrecka-Kuka, PhD
Senior Scientist, Sitryx Therapeutics“GMet has helped us to analyse our in vitro and in vivo model samples. They are great to work with. The team is highly professional and the service they provide is efficient and supportive, starting from experimental design to interpretation of the data. All of this made GMet the right choice for us. We’ve completed both non-targeted metabolomics and isotopic labelling studies that have facilitated our project development, from elucidating mode of actions to pointing us to new potential biomarker strategies.”
Professor Tobias Hohl, MD, PhD
Professor Tobias Hohl, MD, PhD
Memorial Sloan Kettering Cancer Center, NY“We study the gut microbiome of our patients, and the ability to look at metabolomics of large cohorts in an unbiased way through GMet’s platform has changed the way we approach our research. And working with GMet to generate pilot data rapidly was very helpful with our grant application – which got a great score!”
Ralph DeBerardinis, M.D., Ph.D.
Ralph DeBerardinis, M.D., Ph.D.
UT Southwestern & HHMI“Metabolomics has the potential to report on a vast array of biological processes related to health and disease. The metabolomics platform offered by General Metabolics provides extremely fast and comprehensive analysis of metabolite levels, reported in an intuitive and user-friendly interface. I think this is the next step is biomarker discovery.”
